Refine
Has Fulltext
- yes (27)
Is part of the Bibliography
- yes (27)
Year of publication
Document Type
- Journal article (26)
- Report (1)
Language
- English (27)
Keywords
- Chirurgie (3)
- Immunbiologie (2)
- rat (2)
- 15-Deoxyspergualin (1)
- ABCG2 (1)
- AIDS (1)
- Arthropod (1)
- BCOR (1)
- BCORL1 (1)
- BETA-Diversität (1)
- BETA-Multifunktionalität (1)
- BRENDA (1)
- Biodiversität (1)
- Biomarker (1)
- CML (1)
- Class II antigen blockade (1)
- DNA methylferase homolog (1)
- Dünndarm (1)
- First G-APD Cherenkov Telescope (1)
- Forschungsstation Fabrikschleichach (1)
- HIV (1)
- HIV infections (1)
- Human Physiome (1)
- Imaging Air Cherenkov Telescope (1)
- Imatinib (1)
- Immunobiologie (1)
- Langerhans-Inseln (1)
- Lymantria dispar (1)
- M1/M2 macrophages (1)
- MHC Klasse II (1)
- Monoclonal antibody (1)
- Neisseria gonorrhoeae (1)
- Niere (1)
- Prediction (1)
- Ratte (1)
- Sentinel-1 (1)
- TH1-induced senescence (1)
- TH17 cells (1)
- TRNA(ASP) (1)
- Transplantation (1)
- Waldökosystem (1)
- acute myeloid leukemia (1)
- amino acid transporter (1)
- arterial stiffening (1)
- assembly mechanisms (1)
- atherosclerosis (1)
- beech forest (1)
- beta diversity (1)
- beta-multifunctionality (1)
- binding (1)
- biodiversity (1)
- bipartite metabolism (1)
- body size (1)
- bone marrow (1)
- breast cancer (1)
- calcification (1)
- cancer-targeted IL-12 (1)
- canopy herbivory (1)
- carotid artery disease (1)
- community‐weighted mean (1)
- dass II antigen blockade (1)
- dead-wood enrichment (1)
- deadwood enrichment (1)
- defoliation severity (1)
- differentiation (1)
- disease (1)
- dispersal ability (1)
- drospophila (1)
- drug adherence (1)
- environmental filtering (1)
- enzyme activation (1)
- enzyme inhibitors (1)
- essential tremor (1)
- experimental therapy (1)
- follow up (1)
- forest physiognomy (1)
- genetics (1)
- genome-wide association study (1)
- gypsy moth (1)
- habitat heterogeneity (1)
- hematology (1)
- highly-active antiretroviral therapy (1)
- humanized mice (1)
- immune activation (1)
- immunocytokine (1)
- immunosuppression (1)
- immunotherapy (1)
- insect decline (1)
- insect disturbance (1)
- integrative management strategy (1)
- intra-annual time-series (1)
- islets of Langerhans (1)
- kidney (1)
- land sharing (1)
- land use (1)
- long-term monitoring (1)
- loss-of-function (1)
- lowland beech forests (1)
- managing big data (1)
- mechanism (1)
- movement disorders (1)
- near infrared spectroscopy (1)
- neutral processes (1)
- plant composition (1)
- posttranscriptional regulation (1)
- prediction (1)
- preterm infants (1)
- quality-control (1)
- regeneration (1)
- regional cerebral oxygenation saturation (1)
- regional species pool (1)
- remote sensing (1)
- renal transplantation (1)
- repositories (1)
- reproducible science (1)
- restoration strategy (1)
- rhabdomyosarcoma (1)
- risk (1)
- risk stratification (1)
- sRNA (1)
- saproxylic organisms (1)
- saproxylic species (1)
- score (1)
- service infrastructure (1)
- silicon photo multiplier (1)
- skin-to-skin contact (1)
- small bowel (1)
- species traits (1)
- species turnover (1)
- standards (1)
- survival (1)
- swine (1)
- time series (1)
- tool (1)
- transplantation (1)
- tremor (1)
- trophic position (1)
- tumor-infiltrating lymphocytes (1)
- very high energy gamma rays (1)
- viral load (1)
- viral replication (1)
- xenogeneic transplantation (1)
- β-diversity (1)
Institute
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (9)
- Theodor-Boveri-Institut für Biowissenschaften (7)
- Kinderklinik und Poliklinik (3)
- Medizinische Klinik und Poliklinik II (3)
- Julius-von-Sachs-Institut für Biowissenschaften (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Frauenklinik und Poliklinik (1)
- Institut für Geographie und Geologie (1)
- Institut für Klinische Epidemiologie und Biometrie (1)
- Institut für Mathematik (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 229289 (1)
Total immunoreactive insulin (IRI) is conventionally determined by radioimmunoassays. IR! measurement in rats can be made more sensitive, accurate, and practical, as demonstrated by a new modified enzyme-linked immunosorbent assay (ELlSA). It is characterized by indirect binding of an anti-insulin antibody by an antiglobulin antibody and uses the principle of competitive saturation. In this ELlSA, IRI can be determined in a wide range of concentrations, corresponding to the standards. The standard curve ranges from 100 to 0.049 ng/mllRI (1 ng/ml - 23.4 JLU/ml - 172 pM rat insulin). The statistical analysis shows between- and within-assay coefficients of variation of :515%. Diabetes 37:321-26,1988
Stimulating the immune system to attack cancer is a promising approach, even for the control of advanced cancers. Several cytokines that promote interferon-γ-dominated immune responses show antitumor activity, with interleukin 12 (IL-12) being of major importance. Here, we used an antibody-IL-12 fusion protein (NHS-IL12) that binds histones of necrotic cells to treat human sarcoma in humanized mice. Following sarcoma engraftment, NHS-IL12 therapy was combined with either engineered IL-7 (FcIL-7) or IL-2 (IL-2MAB602) for continuous cytokine bioavailability. NHS-IL12 strongly induced innate and adaptive antitumor immunity when combined with IL-7 or IL-2. NHS-IL12 therapy significantly improved survival of sarcoma-bearing mice and caused long-term remissions when combined with IL-2. NHS-IL12 induced pronounced cancer cell senescence, as documented by strong expression of senescence-associated p16\(^{INK4a}\) and nuclear translocation of p-HP1γ, and permanent arrest of cancer cell proliferation. In addition, this cancer immunotherapy initiated the induction of myogenic differentiation, further promoting the hypothesis that efficient antitumor immunity includes mechanisms different from cytotoxicity for efficient cancer control in vivo.
Aim: Despite increasing interest in β-diversity, that is the spatial and temporal turnover of species, the mechanisms underlying species turnover at different spatial scales are not fully understood, although they likely differ among different functional groups. We investigated the relative importance of dispersal limitations and the environmental filtering caused by vegetation for local, multi-taxa forest communities differing in their dispersal ability, trophic position and body size.
Location: Temperate forests in five regions across Germany.
Methods: In the inter-region analysis, the independent and shared effects of the regional spatial structure (regional species pool), landscape spatial structure (dispersal limitation) and environmental factors on species turnover were quantified with a 1-ha grain across 11 functional groups in up to 495 plots by variation partitioning. In the intra-region analysis, the relative importance of three environmental factors related to vegetation (herb and tree layer composition and forest physiognomy) and spatial structure for species turnover was determined.
Results: In the inter-region analysis, over half of the explained variation in community composition (23% of the total explained 35%) was explained by the shared effects of several factors, indicative of spatially structured environmental filtering. Among the independent effects, environmental factors were the strongest on average over 11 groups, but the importance of landscape spatial structure increased for less dispersive functional groups. In the intra-region analysis, the independent effect of plant species composition had a stronger influence on species turnover than forest physiognomy, but the relative importance of the latter increased with increasing trophic position and body size.
Main conclusions: Our study revealed that the mechanisms structuring assemblage composition are associated with the traits of functional groups. Hence, conservation frameworks targeting biodiversity of multiple groups should cover both environmental and biogeographical gradients. Within regions, forest management can enhance β-diversity particularly by diversifying tree species composition and forest physiognomy.
Background
HIV-disease progression correlates with immune activation. Here we investigated whether corticosteroid treatment can attenuate HIV disease progression in antiretroviral-untreated patients.
Methods
Double-blind, placebo-controlled randomized clinical trial including 326 HIV-patients in a resource-limited setting in Tanzania (clinicaltrials.gov NCT01299948). Inclusion criteria were a CD4 count above 300 cells/μl, the absence of AIDS-defining symptoms and an ART-naïve therapy status. Study participants received 5 mg prednisolone per day or placebo for 2 years. Primary endpoint was time to progression to an AIDS-defining condition or to a CD4-count below 200 cells/μl.
Results
No significant change in progression towards the primary endpoint was observed in the intent-to-treat (ITT) analysis (19 cases with prednisolone versus 28 cases with placebo, p = 0.1407). In a per-protocol (PP)-analysis, 13 versus 24 study participants progressed to the primary study endpoint (p = 0.0741). Secondary endpoints: Prednisolone-treatment decreased immune activation (sCD14, suPAR, CD38/HLA-DR/CD8+) and increased CD4-counts (+77.42 ± 5.70 cells/μl compared to -37.42 ± 10.77 cells/μl under placebo, p < 0.0001). Treatment with prednisolone was associated with a 3.2-fold increase in HIV viral load (p < 0.0001). In a post-hoc analysis stratifying for sex, females treated with prednisolone progressed significantly slower to the primary study endpoint than females treated with placebo (ITT-analysis: 11 versus 21 cases, p = 0.0567; PP-analysis: 5 versus 18 cases, p = 0.0051): No changes in disease progression were observed in men.
Conclusions
This study could not detect any significant effects of prednisolone on disease progression in antiretroviral-untreated HIV infection within the intent-to-treat population. However, significant effects were observed on CD4 counts, immune activation and HIV viral load. This study contributes to a better understanding of the role of immune activation in the pathogenesis of HIV infection.
To decrease immunogenicity of the rat kidney, grafts were perfused with an anti-MHC class li monoclonal antibody (mAb ). How effectively this procedure blocked dass li-positive cells, which were mainly dendritic in appearance, was checked by immunostaining renal sections after perfusion and comparing them with in vitro stained sections. Optimum conditions were applied for graft pretreatment before transplantation. This procedure prolonged graft survival, though not satisfactorily from the biological point ofview (9.6 ± 0.8 versus 7.7 ± 0.5 days in the control group; P < 0.02). The dendritic cells were not killed but blocked. Several hours after transplantation, the mAb dissociated from these dass li-positive cells. It was also shown that donor cells migrate into the recipient's spieen early after transplantation. The number of these cells was smaller when the transplanted organ was perfused with the mAb. Further studies are suggested to deplete the graft of donor dendritic cells more adequately. They should also combine graft perfusion with antidass II mAb and recipient immunosuppression at reduced doses.
An immunogold-silver enhancement technique, which combines effective labeling of viable isolated islets with the ultrastructural resolution of cytological details, was applied in electron microscopy to identify major histocompatibility complex (MHC) structures on islet cells. Incubation of freshly isolated islets from CAP (RT1C) and LEW (RT1') rats with OX18, an MHC class I antibody, showed strong positive reactivity in macrophages and/or dendritic-like cells (M0-DCs) and vascular endothelial cells (VEs) and a comparatively weaker reactivity in endocrine a-, p-, and 8-ce"s. With MHC class" antibody OX6 (anti-I-A), M0-DCs were strongly labeled in both rat strains on the surface and on internal structures. Three of five particularly high titered batches of OX6 revealed MHC class" expression on VE and p-ce"s. Four days of in vitro culture in combination with a high concentration of glucose and interferon-'Y induced strong enhancement of MHC class I structures and, to a lesser extent, class " structures on p-ce"s.
Because successful human islet transplantation requires large quantities of viable islets that must be separated from the highly immunogenic exocrine tissue and because handpicking is too time-consuming and laborious to be clinically relevant, a new approach for solving this problem has been established in rat models. It is based on the principle that magnetic microspheres (MMSs) coupled to lectins with binding specificity for the exocrine tissue portion are trapped in an electromagnetic field, thus providing effluent islets of a high degree of purity. In this study our aim was to adapt this princip'le to human islet preparations. In this context our prime interest was focused on a lectin suitable for human pancreatic tissue. Of 19 different lectins tested, only 1, Wisteria floribunda agglutinin (WFA), is suitable, as shown by immunofluorescence, MMS-Iectin binding, and magnetic separation
During the past few years, interest in xenotransplantation of porcine islets of Langerhans for the future therapy of type I diabetes has Increased markedly. Therefore, we established a semiautomated digestion method for isolating islets from the porcine pancreas. However, although the isolation technique was standardized and collagenase of controlled quality was used, we were unable to attain high islet yields with a satisfactory degree of reproducibility. One hypothesis was that varying degrees of interference by donor pancreatic enzymes were responsible for this failure. The aim of this stUdy was to examine the kinetics of four types of enzymatic activity during the isolation procedure, as well as their effects on islet yield: collagenase, trypsin, neutral protease, and clostripaln. Our results indicate that while exogenous collagenase activity decreases slightly during the isolation procedure, the activity of the pancreas enzymes neutral protease and trypsin increases. In some cases, trypsin activity increases very strongly. A strong increase in trypsin activity correlates with poor islet yield, whereas low trypsin activity always correlates with high islet yield. Addition of the protease inhibitor Pefabloc to the isolation medium results in low trypsin activity and reproducible high islet yields.
Since systematic hematological studies on blood and bone marrow changes after treatment with 15-Deoxyspergualin (DOS) are lacking, a quantitative assessment was performed fourteen or twenty eight days after intraperitoneal application of DOS to rats. Further observations done 7 and 14 days after discontinuation of DOS administration allowed analysis of banc marrow regeneration. DOS induced lymphocytopenia, granUlocytopenia and anemia with a decrease of bone marrow cellularity due to suppression of cell maturation. The effect was dose-dependent and bone marrow as well as blood changes were observed in animals treated with doses from 0.5 to 10.0 mg/kg DOS. Within 14 days after termination of the treatment, rapid recovery with normalization of all hematological parameters was observed. In the light of our data, these hematological side effects may not be a major disadvantage, if DOS is used in doses below 2.5 mg/kg, and for a course of therapy which is limited to 7 to 14 days.